Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Wed, 07.02.2024
Nordea Bank Abp
Nordea Bank Abp
/ Key word(s): Transaction in Own Shares
Transaction in Own Shares
07.02.2024 / 08:20 CET/CEST
Nordea Bank Abp: Repurchase of own shares on 06.02.2024
Nordea Bank Abp
Stock exchange release - Changes in company's own shares
06.02.2024 at 22.30 EET
Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 06.0 [ … ]
Wed, 07.02.2024
USU Software AG
Möglingen, February 07, 2024
USU announced today that it has been named "Liferay Partner of the Year" for EMEA (Europe, Middle East, Africa). This award recognizes partners who have excelled internationally in delivering powerful digital experience solutions on the Liferay platform, helping organizations meet critical business needs. USU was awar [ … ]
Wed, 07.02.2024
Pyrum Innovations AG
Pyrum Innovations AG: New reactor in Dillingen already at 75% output during second start-up run
New reactor 2 (TAD 2) in Dillingen runs stably at 75% of nominal output
Successful production of 30,000 litres of oil during second test run
Warm commissioning of TAD 3 is expected to follow by the end of March 2024
Dillingen / Saar, 7 February 2024 - [ … ]
Wed, 07.02.2024
Holcim Group Services Ltd
Holcim Group Services Ltd
/ Key word(s): Miscellaneous
Holcim acquires ZinCo to advance green roofing systems 07.02.2024 / 07:47 CET/CEST
Global leader in advanced green roofing systems
Expanding Holcim’s systems selling from solar to green roofs
Holcim has acquired ZinCo, a leader in advanced green roofing systems based i [ … ]
Wed, 07.02.2024
Marinomed Biotech AG
Marinomed Biotech AG with important progress for Carragelose in 2024
First patient enrolled in clinical study investigating the moisturizing effectiveness of Carragelose eye drops
Clinical data showing the effectiveness of Carragelose in alleviating allergic symptoms in patients with grass pollen allergy published in peer-reviewed International J [ … ]
Wed, 07.02.2024
CTS Eventim AG & Co. KGaA
AD HOC DISCLOSUREPublic disclosure of inside information in accordance with Article 17 of Regulation (EU) No. 596/2014 (Market Abuse Regulation)
CTS EVENTIM: Dynamic growth across all business segments produces record results for 2023
Munich, 7 Feb. 2024 – According to preliminary results, CTS EVENTIM AG & Co. KGaA again delivered dynamic gro [ … ]
Wed, 07.02.2024
Evotec SE
JUST – EVOTEC BIOLOGICS TO PROVIDE DEVELOPMENT AND PHASE I CLINICAL MANUFACTURING OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV
AGREEMENT BUILDS ON PREVIOUS NIAID-FUNDED COLLABORATION TO DEVELOP A BROADLY NEUTRALISING ANTIBODY AGAINST HIV
Hamburg, Germany, 07 February 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; [ … ]
Wed, 07.02.2024
voestalpine AG
Economic slowdown impacts voestalpine earnings for Q3 2023/24
At EUR 12.4 billion, revenue for Q1 to Q3 2023/24 is 8.8% lower than in the previous year (EUR 13.6 billion)
EBITDA fell by 31.7% to EUR 1.3 billion (previous year: EUR 1.9 billion)
EBIT decreases year-over-year from EUR 1.1 billion to EUR 713 million (–37.4%)
Profit before tax at EU [ … ]
Wed, 07.02.2024
Hannover Rück SE
Corporate news
Hannover Re confirms guidance for 2024 on the back of further improvements in terms and conditions and sustained attractive prices
Growth of 6.9% with further improvements in terms and conditions in the 1 January property and casualty reinsurance renewals
Average inflation- and risk-adjusted price increase of 2.3%
Focus on susta [ … ]
Wed, 07.02.2024
CompuGroup Medical SE & Co. KGaA
CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin
Group revenues increase by 5% to EUR 1.19 billion in 2023
Organic growth of 4.3% (5.3% ex TI) compared to strong previous year
Share of recurring revenue climbs to new high of 69%
Adjusted EBITDA increases by 13% to EUR 265 millio [ … ]